Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
2019 · Neuro-Oncology · 130 citations
https://doi.org/10.1093/neuonc/noz011
H
Helena Carén
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
137
Papers
3.1K
Citations
31
h-index
56
i10-index
Helena Carén is an academic researcher from National Academy of Medicine. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Neuroblastoma Research and Treatments & Epigenetics and DNA Methylation. The author has an h-index of 31, co-authored 117 publications.
ORCID: 0000-0002-8584-555XPapers by this author
worksGlioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest
2015 · Stem Cell Reports · 119 citations
https://doi.org/10.1016/j.stemcr.2015.09.014
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
2012 · Molecular Cancer · 87 citations
https://doi.org/10.1186/1476-4598-11-40
Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours
2007 · British Journal of Cancer · 63 citations
https://doi.org/10.1038/sj.bjc.6604032
COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status
2011 · BMC Cancer · 53 citations
https://doi.org/10.1186/1471-2407-11-238
The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study
2020 · BMC Cancer · 51 citations
https://doi.org/10.1186/s12885-020-06951-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat